Back to search

National and Kapodistrian University of Athens

Έρευνα και ανάπτυξη αποτελεσματικού και ασφαλούς για τον οργανισμό συστήματος μεταφοράς φαρμακευτικών δραστικών ουσιών, συνδυάζοντας την τεχνολογία των νιοσωμάτων και των πολυμερών με σκοπό την παραγωγή μια καινοτόμας και χαμηλού κόστους νανο-πλατφόρμας μεταφοράς αντικαρκινικών παραγόντων

Abstract

dc:description

During the last years, a steady increase of the pharmaceutical compounds that receive authorization and enter the market that exhibit low bioavailability, due to characteristics such as low solubility and high hydrophobicity is recorded. Up to 90% of new pharmaceutical active molecules/ingredients that exhibit a biological interest belong to BCS class II or IV, most of which exhibit at the same time low cellular absorbance. Among these compounds are products that show antitumor activity, by reducing cancer cell proliferation, the administration of which is classified as risk in today’s clinical practice. Additionally, other limitations that many conventional drug compounds exhibit are the inability to successfully deliver a high amount of active ingredient molecules in the pathogenic cite of interest, while at the same time providing a steady, prolonged release rate. The specific characteristics and properties that material at the nanoscale offer, provides us the potential for the creation of smart nanosystems for the encapsulation and controlled and/or targeted delivery of active pharmaceutical ingredients, capable to achieve the selective delivery of therapeutic molecules to target cells, with the ultimate goal of improving the final clinical picture. The aim of the present research was to prepare a novel, hybrid copolymer-surfactant nanosystem using the block-copolymer Pluronic 188, combined with the use of amphiphilic surfactants of lower molecular weight (particular emphasis will be given to the HLB ratio - which indicates the degree to which a surfactant is comprised of more hydrophilic or hydrophobic counterparts) and thermotropic behavior. The surfactants used were non-ionic in nature, of which Tween 80® and Brij 58® were more hydrophilic, while Span 40® and Span 60® were more hydrophobic. Each surfactant has unique intrinsic thermal properties and molecular interactions with respect to the molecules of Pluronic 188. The nanosystems were formed by mixing the block-copolymer with the surfactants in three different (w/w) ratios, namely 90:10, 80:20 and 50:50, using the thin film hydration technique and keeping the concentration of Pluronic 188 constant. The physicochemical characteristics of the prepared nanosystems were evaluated by various light scattering techniques, while their thermotropic behavior was characterized by microDSC and high-resolution acoustic spectroscopy (HR-US). Using fluorescence spectroscopy, additional information regarding characteristics such as microfluidity and microviscosity of the nanosystems were obtained, while the cytotoxicity of the nanocarriers was studied comparatively, both using carriers with encapsulated amounts of the anti-cancer molecule methotrexate (MTX), as well as using empty nanosystems, in vitro and in vivo. Pharmacokinetic characteristics that give these anti-cancer drug delivery systems a significant advantage over more conventional therapeutic approaches, such as the gradual release of encapsulated active substances, as well as the ability to encapsulate and deliver large amounts of active substances were studied using UV-Vis, and dialysis bag (use of a membrane with pores of a specific diameter). It is worth noting that this effort is the first time that such a system is studied in extent holistically, from the early stages of formulation (physicochemical characterization) to in vivo experimentation, and is presented in a single manuscript, illustrating how multiple parameters can affect the final nanomedicine.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kontogiannis, Orestis
  • Κοντογιάννης, Ορέστης

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58825

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kontogiannis, Orestis; Κοντογιάννης, Ορέστης. Έρευνα και ανάπτυξη αποτελεσματικού και ασφαλούς για τον οργανισμό συστήματος μεταφοράς φαρμακευτικών δραστικών ουσιών, συνδυάζοντας την τεχνολογία των νιοσωμάτων και των πολυμερών με σκοπό την παραγωγή μια καινοτόμας και χαμηλού κόστους νανο-πλατφόρμας μεταφοράς αντικαρκινικών παραγόντων. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/58825